In this article we intention to deliver a narrative critique from the literature about intraperitoneal pentobarbital being a killing method, Consider its present-day designation as ‘satisfactory’ (because of the AVMA and CCAC), determine gaps in expertise Which might be pertinent towards the refinement of this method, and propose potential opti